Albuterol
Result: $150 million settlement
Year: 1995
In re Copley Pharmaceutical, Inc., “Albuterol” Products Liability Litigation
Lieff Cabraser served on the Plaintiffs’ Steering Committee in a class action lawsuit against Copley Pharmaceutical, which manufactured Albuterol, a bronchodilator prescription pharmaceutical. Albuterol was the subject of a nationwide recall in January 1994 after a microorganism was found to have contaminated the solution, allegedly causing numerous injuries including bronchial infections, pneumonia, respiratory distress and, in some cases, death.
In October 1994, the district court certified a nationwide class on liability issues. In re Copley Pharmaceutical, 161 F.R.D. 456 (D. Wyo. 1995). In November 1995, the district court approved a $150 million settlement of the litigation.
Civil Litigation News
Judge Will Grant Preliminary Approval to $255M Economic Loss Settlement Against Juul
As reported by Law360, on January 20, 2023, U.S. District Judge William H. Orrick of the Federal District Court for the Northern District
Consumer Class Action Over Evenflo Child Car Seats to Move Forward
On Wednesday, January 3, 2023, The 1st Circuit Court of Appeal in Boston declined to rehear its November 23rd decision reviving the
Federal Court says Evenflo must face ‘Big Kid’ booster seat safety litigation
The 1st Circuit Court of Appeal in Boston has revived class action litigation accusing Evenflo Company Inc of misleading consumers about the
